Common Misinformation about Prostate Cancer and What to Do - Webinar

Misinformation about prostate cancer is widespread in online networks and commonly raised during clinical encounters. Failing to address information can result in harms for patients, and challenging discussions about misinformation can lead to discord in the patient-clinician relationship. It is important that radiation oncologists are aware of the most common types of misinformation that are circulating about prostate cancer. Radiation oncologists need strategies to help combat misinformation about prostate cancer and to handle patient encounters where misinformation is discussed. 

In this presentation we will discuss the most common types of misinformation that are circulating about prostate cancer. We will also review strategies to use in clinical encounters with patients where misinformation is discussed. 

Live webinar: June 8, 2026 - 1:00 p.m. ET

This activity will be available from June 8, 2026 to June 7, 2028.

Continuing education credit is available for this activity until July 8, 2026.

Target Audience

The activity is designed to meet the interests of radiation oncologists, medical oncologists, residents, surgeons and nurses. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • List common myths that are circulating about prostate cancer in online networks.
  • Apply strategies to address misinformation while maintaining the patient-physician relationship. 
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
04/08/2026
Course expires: 
06/07/2028
Cost:
$49.00
Rating: 
0

Moderator:

  • Neha Vapiwala, MD, FASTRO, FACR, is employed by the University of Pennsylvania. Dr. Vapiwala has no relevant financial relationship with ineligible companies to disclose. 

Speaker:

  • Stacy Loeb, MD, MSc., PhD (Hon), is employed by New York University Langone Health and Manhattan Veterans Affairs. Dr. Loeb receives compensation/payment from Savor Health and grant/research funding from Endo USA, Inc. Dr. Loeb received compensation/payment from Astellas (relationship ended 9/30/2025), Sumitomo (relationship ended 10/3/2025) and Pfizer (relationship ended 10/29/2025). 

Planners:

  • Malcolm Mattes, MD is employed at Rutgers Cancer Institute. Dr. Mattes received research/grant funding from Gilead Sciences (relationship ended 8/30/2025). Dr. Mattes has no relevant financial relationship with ineligible companies. 
  • Parul Barry, MD, is employed by the University of Pittsburgh Medical Center. Dr. Barry has no relevant financial relationship with ineligible companies. 
  • Michael Haddock, MD, is employed by Mayo Clinic and has no relevant financial relationship with ineligible companies to disclose.
  • Manisha Palta, MD, is employed by Duke Cancer Center and Duke University Hospital. Dr. Palta receives grant/research funding from Merck and Varian Medical Systems. 
  • Salma Jabbour, MD, is employed by Rutgers Cancer Institute. Dr. Jabbour receives grant/research funding from Merck & Co., Inc. and Beigene. Dr. Jabbour receives compensation/payment as a consultant with Radialogica and IMX Medical. 

All relevant financial relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Continuing education credits for this activity must be claimed by July 8, 2026 by completing the evaluation.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$49.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.

  • Nonmember: $49
  • Member: $0
  • Member-in-Training: $0
  • Student/Graduate Student/PGY-1 Member: $0
  • Postdoctoral Fellow Member: $0

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date. 

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until April 7, 2028, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date. 

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.